共 43 条
Treatment of Acinetobacter Infections
被引:264
作者:
Fishbain, Joel
[1
]
Peleg, Anton Y.
[2
,3
,4
,5
]
机构:
[1] St John Hosp & Med Ctr, Div Infect Dis, Detroit, MI USA
[2] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Alfred Hosp, Melbourne, Vic, Australia
[5] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia
关键词:
CRITICALLY-ILL PATIENTS;
BLOOD-STREAM INFECTION;
PSEUDOMONAS-AERUGINOSA;
ATTRIBUTABLE MORTALITY;
CALCOACETICUS COMPLEX;
AMPICILLIN-SULBACTAM;
BAUMANNII BACTEREMIA;
COMBINATION THERAPY;
IMIPENEM-CILASTATIN;
MEROPENEM;
D O I:
10.1086/653120
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.
引用
收藏
页码:79 / 84
页数:6
相关论文